In addition to well-known predictors of favorable outcome in PAH, namely younger age, and FC, 6-MWD and NT-proBNP within low-risk range, our study shows that PoPH and HIV-PAH subtypes are independent predictors of a favorable response to PDE-5i treatment. Here, NPPB is linked to pulmonary arterial hypertension.